The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III
- PMID: 20535350
- PMCID: PMC2879846
- DOI: 10.5056/jnm.2010.16.2.186
The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III
Abstract
Background/aims: Irritable bowel syndrome (IBS) is one of the most frequently observed disorders by primary care and practitioners. The aim of this study was to estimate the prevalence of IBS using the Rome II and III criteria in the general Korean population and also to compare sociodemographic differences between subjects diagnosed by these criteria.
Methods: Telephone interview surveys were performed with a total of 1,009 individuals in Korea, 15 years of age or older. The questionnaire, based on the Rome II and III criteria, was validated.
Results: Among the 1,009 subjects, the prevalence of IBS was 8.0% under the Rome II criteria (81 subjects; 6.4%, male; 9.6%, female), and 9.0% (91 subjects; 7.0%, male; 11.0%, female) under the Rome III criteria. The accordance rate of Rome II and III was 73.5%. Both groups showed highest frequency in the age of 30s (13.9% vs. 15.3% respectively). Female subjects showed a higher prevalence than male subjects under Rome III (91 subjects; 11.0% in female, 7.0% in male; p < 0.05), but not under Rome II criteria. Many patients older than 50 years were added when analyzed under the Rome III criteria, but not under the Rome II criteria (p = 0.017).
Conclusions: The Rome III criteria were less restrictive and showed good agreement with the Rome II criteria. The prevalence of IBS was increased in young women.
Keywords: Irritable bowel syndrome; Prevalence; Rome II; Rome III.
Conflict of interest statement
Conflicts of interest: None.
Figures

Similar articles
-
[A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].Zhonghua Nei Ke Za Zhi. 2007 Aug;46(8):644-7. Zhonghua Nei Ke Za Zhi. 2007. PMID: 17967234 Chinese.
-
Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.Am J Gastroenterol. 2013 Jun;108(6):972-80. doi: 10.1038/ajg.2013.15. Epub 2013 Feb 19. Am J Gastroenterol. 2013. PMID: 23419383
-
Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria.Patient Prefer Adherence. 2008 Feb 2;2:143-7. Patient Prefer Adherence. 2008. PMID: 19920955 Free PMC article.
-
Applying case definition criteria to irritable bowel syndrome.Clin Med Res. 2008 May;6(1):9-16. doi: 10.3121/cmr.2008.788. Clin Med Res. 2008. PMID: 18591372 Free PMC article. Review.
-
Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review.Am J Gastroenterol. 2010 Apr;105(4):814-20; quiz 813, 821. doi: 10.1038/ajg.2010.56. Epub 2010 Feb 23. Am J Gastroenterol. 2010. PMID: 20179688 Free PMC article. Review.
Cited by
-
Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?J Neurogastroenterol Motil. 2010 Jul;16(3):342. doi: 10.5056/jnm.2010.16.3.342. Epub 2010 Jul 26. J Neurogastroenterol Motil. 2010. PMID: 20680182 Free PMC article. No abstract available.
-
Prevalence of irritable bowel syndrome: a community based study from northern India.J Neurogastroenterol Motil. 2011 Jan;17(1):82-7. doi: 10.5056/jnm.2011.17.1.82. Epub 2011 Jan 26. J Neurogastroenterol Motil. 2011. PMID: 21369496 Free PMC article.
-
Prevalence of Irritable Bowel Syndrome in Japan, China, and South Korea: An International Cross-sectional Study.J Neurogastroenterol Motil. 2023 Apr 30;29(2):229-237. doi: 10.5056/jnm22037. J Neurogastroenterol Motil. 2023. PMID: 37019867 Free PMC article.
-
Irritable Bowel Syndrome: A Global Challenge Among Medical Students.Cureus. 2016 Aug 1;8(8):e721. doi: 10.7759/cureus.721. Cureus. 2016. PMID: 27625907 Free PMC article. Review.
-
Irritable bowel syndrome and other gastrointestinal disorders: evaluating self-medication in an Asian community setting.Int J Clin Pharm. 2012 Aug;34(4):561-8. doi: 10.1007/s11096-012-9644-0. Epub 2012 May 3. Int J Clin Pharm. 2012. PMID: 22552577
References
-
- Horwitz BJ, Fisher RS. The irritable bowel syndrome. N Engl J Med. 2001;344:1846–1850. - PubMed
-
- Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108–2131. - PubMed
-
- Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology. 1991;100:998–1005. - PubMed
LinkOut - more resources
Full Text Sources